Skip to Content

M C27 (Clopidogrel bisulfate 75 mg (base))

Pill imprint M C27 has been identified as Clopidogrel bisulfate 75 mg (base).

Clopidogrel is used in the treatment of ischemic stroke; transient ischemic attack; heart attack; ischemic stroke, prophylaxis; peripheral arterial disease (and more), and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Clopidogrel 75 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Clopidogrel bisulfate 75 mg (base) M C27
Discount Card Promo
Clopidogrel bisulfate
Imprint:
M C27
Strength:
75 mg (base)
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Platelet aggregation inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals, Inc.
National Drug Code (NDC):
00378-3627
Inactive Ingredients:
lactose anhydrous
silicon dioxide
croscarmellose sodium
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
sodium lauryl sulfate
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0557 UDL Laboratories Inc

Note: Inactive ingredients may vary.

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide